Get started
Author

Gordon Beattie

Observed names: Beattie, Gordon, G Beattie, Gordon, Beattie
ORCID: 0009-0005-4455-8369
Observed ORCID: 0009-0005-4455-8369
OpenAlex ID: A5006988780
Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma
2021 · Lewis Au, Emine Hatipoglu, et al. · Cancer Cell · 271
PDF
Glioblastoma cell fate is differentially regulated by the microenvironments of the tumor bulk and infiltrative margin
2023 · Claudia Garcia-Diaz, Anni Pöysti, et al. · Cell Reports · 71
PDF
Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodies
2025 · Felipe Galvez-Cancino, Mariela Navarrete, et al. · Immunity · 43
Axonal injury is a targetable driver of glioblastoma progression
2025 · Melanie Clements, Wenhao Tang, et al. · Nature · 35
CTLA-4 expressing innate lymphoid cells modulate mucosal homeostasis in a microbiota dependent manner
2024 · Jonathan Lo, Jan-Hendrik Schroeder, et al. · Nature Communications · 26
PDF
Tumour-intrinsic features shape T cell differentiation through precursor to symptomatic multiple myeloma
2026 · Kane A. Foster, Elise Rees, et al. · Nature Communications · 17
Nonsense-mediated mRNA decay inhibition reshapes the cancer immunopeptidome
2026 · Roberto Vendramin, Hongchang Fu, et al. · Immunity · 11
Determinants of Anti-PD1 Response and Resistance in Clear Cell Renal Cell Carcinoma
2021 · Lewis Au, Emine Hatipoglu, et al. · SSRN Electronic Journal · 8
Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodies
2025 · Felipe Galvez-Cancino, Mariela Navarrete, et al. · Immunity · 6
Autophagy is an upstream mediator of chromatin dynamics in normal and autoimmune germinal center B cells
2025 · Marta C. Sallan, Filip Filipsky, et al. · Journal of Clinical Investigation · 6
PDF
CD90 is not constitutively expressed in functional innate lymphoid cells
2023 · J-H Schroeder, G Beattie, et al. · Frontiers in Immunology · 6
PDF
156O Pharmacologic inhibition of nonsense-mediated decay induces anti-tumour immunogenicity in ex vivo patient tumours
2024 · Roberto Vendramin, Hongchang Fu, et al. · ESMO Open · 4
PDF
A non-canonical lymphoblast in refractory childhood T-cell leukaemia
2025 · Bram S. J. Lim, Holly J. Whitfield, et al. · Nature Communications · 2
A Non-Canonical Lymphoblast in Refractory Childhood T-Cell Acute Lymphoblastic Leukemia
2024 · Bram S.J. Lim, Holly J. Whitfield, et al. · Blood · 2
Tumour-Intrinsic Features Shape T-Cell Differentiation through Myeloma Disease Evolution
2024 · Kane A Foster, Elise Rees, et al. · Blood · 2
Abstract 6737: Pharmacologic modulation of nonsense-mediated decay induces anti-tumor immunogenicity in ex vivo patient tumors
2024 · Roberto Vendramin, Hongchang Fu, et al. · Cancer Research · 2
OAB-024: T cell differentiation in the bone marrow during disease evolution: insights from COSMOS and integrative analysis of 317,000 single-cell transcriptomes
2022 · Kane Foster, Elise Rees, et al. · Clinical Lymphoma Myeloma & Leukemia · 2
Tumour endothelial cell reprogramming orchestrates angiocrine signalling to drive chemoresistance in breast cancer
2026 · Jesus Gomez-Escudero, Eleni Maniati, et al. · Angiogenesis · 1
PDF
MIF mediates monocyte-dependent inhibition of natural killer cell cytotoxicity in triple-negative breast cancer
2026 · Christos Ermogenous, Marti Brucoli, et al. · Cell Reports · 1
FasL-Mediated Death of Activated Intratumoral T Cells Drives Secondary Resistance to Cancer Immunotherapy
2026 · Chen Qing, Ehsan Ghorani, et al. · Cancer Immunology Research
Multi-omics reveals a monocyte-macrophage-fibroblast axis in post-COVID-19 fibroinflammatory lung remodelling
2026 · Puja Mehta, Connar M. A. Mawer, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
A93-02 The Bronchoalveolar and Systemic Immune Landscape in Post-Covid-19 Residual Lung Abnormalities (RLA)
2026 · P Mehta, C Mawer, et al. · American Journal of Respiratory and Critical Care Medicine
Abstract 6742: Nonsense-mediated mRNA decay inhibition augments in vitro, in vivo , and ex vivo anti-tumor immunity
2026 · Hongchang Fu, Roberto Vendramin, et al. · Cancer Research
In Vivo transfer of CD4+ T cells reshapes CD8+ T cell differentiation trajectory in humans
2025 · Andrew McIntyre, Maria Cuadrado, et al. · Blood
Os05.3.a Axonal Injury Is a Targetable Driver of Glioblastoma Progression
2025 · Z Florjanic Baronik, M Clements, et al. · Neuro-Oncology
PDF
Works count: 38
Citation count: 517
H-index: 8
I10-index: 7
Year
Topic
Type